Sveriges mest populära poddar
Business Wars
HistoriaNäringsliv

Ozempic Wars | The Next Injection | 2

37 min•26 november 2025

Novo Nordisk can't keep up with demand for Ozempic and Wegovy, giving competitor Eli Lilly the edge in the GLP-1 market. And off-brand competitors continue to hammer the company's market position. Layoffs and board resignations signal that Novo Nordisk has entered a downward spiral. But with new leaders, acquisitions and deals, can they force a comeback?

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Fler avsnitt av Business Wars

Visa alla avsnitt av Business Wars
Spotify vs Apple Music | Who Stopped the Music? | 1
•44 min
Under Armour's Attack on Nike | Signature Sneakers | 3
•42 min
Under Armour's Attack on Nike | Dropping the Ball | 2
•45 min
Under Armour's Attack on Nike | Sweat Equity | 1
•44 min
Gatorade Sweats the Competition | Defending the Title | 3
•38 min
Gatorade Sweats the Competition | Be Like Mike | 2
•35 min
Gatorade Sweats the Competition | Searching for a Solution | 1
•44 min
The Buy Now Pay Later Takeover | Fake Money | 3
•41 min
The Buy Now Pay Later Takeover | Maxing Out | 2
•41 min
The Buy Now Pay Later Takeover | No Interest | 1
•42 min

Business Wars med Audible finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.